NOVEL AURISTATIN ANALOGS AND IMMUNOCONJUGATES THEREOF

MAGNETIC RESONANCE IMAGE PROCESSING APPARATUS AND METHOD TO WHICH IMPROVEMENT IN SLICE RESOLUTION IS APPLIED

IMMUNOGLOBULINS AND USES THEREOF

CONJUGATES AND METHODS OF USING THE SAME

DECARBOXYLATIVE CONJUGATE ADDITIONS AND APPLICATIONS THEREOF

HEMIASTERLIN DERIVATIVES FOR CONJUGATION AND THERAPY

XTEN CONJUGATE COMPOSITIONS AND METHODS OF MAKING SAME

CYCLIC PEPTIDE TYROSINE TYROSINE COMPOUNDS AS MODULATORS OF NEUROPEPTIDE Y RECEPTORS

Cytotoxic and anti-mitotic compounds, and methods of using the same

ANTIBODY-COUPLED CYCLIC PEPTIDE TYROSINE TYROSINE COMPOUNDS AS MODULATORS OF NEUROPEPTIDE Y RECEPTORS

Cytotoxic and anti-mitotic compounds, and methods of using the same

EFFICIENT PREPARATION OF DOLASTATIN AND AURISTATIN ANALOGS THROUGH A COMMON INTERMEDIATE

AURISTATIN-RELATED COMPOUNDS, CONJUGATED AURISTATIN-RELATED COMPOUNDS, AND METHODS OF USE THEREOF

DERIVATIVES OF DOLASTATIN 10 AND AURISTATINS

COMPOSITIONS CONTAINING, METHODS INVOLVING, AND USES OF NON-NATURAL AMINO ACID LINKED DOLASTATIN DERIVATIVES

DERIVATIVES OF DOLAPROINE-DOLAISOLEUINE PEPTIDES

METHOD FOR PREPARING DRUG-LINKER MC-MMAF FOR ANTIBODY DRUG CONJUGATE, AND INTERMEDIATES THEREIN

PROSTATE-SPECIFIC MEMBRANE ANTIGEN ANTIBODY DRUG CONJUGATES

Decarboxylative conjugate additions and applications thereof

XTEN CONJUGATE COMPOSITIONS AND METHODS OF MAKING SAME

Heteroaryl sulfone-based conjugation handles, methods for their preparation, and their use in synthesizing antibody drug conjugates

Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives

HEMIASTERLIN DERIVATIVES FOR CONJUGATION AND THERAPY

Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors

Hemiasterlin derivatives for conjugation and therapy

Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors

Conjugates and methods of using the same

DERIVATIVES OF DOLASTATIN 10 AND AURISTATINS

Immunoglobulins and uses thereof

Immunoglobulins and uses thereof

Albumin-binding prodrugs of auristatin E derivatives

Derivatives of dolaproine-dolaisoleucine peptides

ANTI-CANCER COMPOUNDS AND CONJUGATES THEREOF

CD48 ANTIBODIES AND CONJUGATES THEREOF

Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors

Hemiasterlin derivatives and antibody-drug conjugates including same

N-acyldipeptide derivatives and their uses

Cytotoxic and anti-mitotic compounds, and methods of using the same

Tripeptide epoxy ketone protease inhibitors

Peptide-Based Quorum Sensing Inhibitors for the Attenuation of Virulence in Staphylococcus Aureus

PRODRUG OF AN ICE INHIBITOR

Growth Hormone Releasing Peptides

DERIVATIVES OF DOLASTATIN 10 AND AURISTATINS

MALT1 inhibitors and uses thereof

Cytotoxic peptides and conjugates thereof

Immunoglobulins and uses thereof

CYTOTOXIC AND ANTI-MITOTIC COMPOUNDS, AND METHODS OF USING THE SAME

Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors

Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors

Cytotoxic and anti-mitotic compounds, and methods of using the same

Immunoglobulins and uses thereof

Difluoroketamide derivatives as HTRA1 inhibitors

XTEN conjugate compositions and methods of making same

CHIRAL COMPOUNDS OF VARYING CONFORMATIONAL RIGIDITY AND METHODS OF SYNTHESIS

Quinstatin compounds

MONOMETHYLVALINE COMPOUNDS HAVING PHENYLALANINE SIDE-CHAIN MODIFICATIONS AT THE C-TERMINUS

PRODRUG OF AN ICE INHIBITOR

Combination of N-acyldipeptide derivatives and retinol, and methods of use thereof

Anti-cancer compounds and conjugates thereof

MALT1 inhibitors and uses thereof

Cytotoxic peptides and conjugates thereof

DERIVATIVES OF DOLASTATIN 10 AND AURISTATINS

Cytotoxic and anti-mitotic compounds, and methods of using the same

Decarboxylative conjugate additions and applications thereof

Cytotoxic peptides and conjugates thereof

Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors

Immunoglobulins and uses thereof

Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors

CD48 antibodies and conjugates thereof

Difluoroketamide derivatives

Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives

Growth Hormone Releasing Peptides

METHOD OF MAKING PRODRUGS AND TARGETED THERAPEUTIC COMPOUNDS

ANTIBODY-DRUG CONJUGATE OF AN ANTI-GLYPICAN-3 ANTIBODY AND A TUBULYSIN ANALOG, PREPARATION AND USES

Cytotoxic and anti-mitotic compounds, and methods of using the same

HCV NS-3 serine protease inhibitors

DERIVATIVES OF DOLAPROINE-DOLAISOLEUINE PEPTIDES

N-acyldipeptide derivatives and their uses

Hydroxystatin derivatives for the treatment of arthrosis

Prodrug of an ICE inhibitor

Tripeptide epoxy ketone protease inhibitors

Cytotoxic peptides and conjugates thereof

Gamma amino acid building blocks

Hemiasterlin derivatives for conjugation and therapy

Aminostatin derivatives for the treatment of arthrosis

PEPTIDE-BASED QUORUM SENSING INHIBITORS FOR THE ATTENUATION OF VIRULENCE IN STAPHYLOCOCCUS AUREUS

Chromobacterium bioactive compositions and metabolites

Cytotoxic and anti-mitotic compounds, and methods of using the same

DERIVATIVES OF DOLASTATIN 10 AND AURISTATINS

DERIVATIVES OF DOLASTATIN 10 AND AURISTATINS

Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives

Cytotoxic and anti-mitotic compounds, and methods of using the same

Dipeptide and tripeptide epoxy ketone protease inhibitors

Auristatin tyramine phosphate salts and auristatin aminoquinoline derivatives and prodrugs thereof

Prodrug of an ice inhibitor

Dolastatin-10 derivative, method of producing the same and anticancer drug composition containing the same

Hydroxystatin derivatives for the treatment of arthrosis

Prostate-specific membrane antigen antibody drug conjugates

Gamma amino acid building blocks

Methods of using monomethylvaline compositions having phenylalanine carboxy modifications at the C-terminus

XTEN conjugate compositions and methods of making same

Growth hormone releasing peptides

Cytotoxic peptides and antibody drug conjugates thereof

Cytotoxic and anti-mitotic compounds, and methods of using the same

Chiral oligomeric pentenoate amides as bio-oligomer mimetics

Chromobacterium bioactive compositions and metabolites

Crystal structures of dolastatin 16, dolamethylleuine and dolaphenvaline, and methods for preparing dolamethylleuine and dolaphenvaline

N-carboxyalkylauristatins and use thereof

Auristatin drug linker conjugates

Auristatin tyramine phosphate salts and auristatin aminoquinoline derivatives and prodrugs thereof

Oligopeptides and process for preparation thereof

Prodrug of an ice inhibitor

Aminostatin derivatives for the treatment of arthrosis

Selective inhibitors of prolylcarboxypeptidase

N-carboxyalkyl-auristatin and the use thereof

Cytotoxic peptides and antibody drug conjugates thereof

Monomethylvaline compounds having phenylalanine side-chain modification at the C-terminus

Growth hormone releasing peptides

NEW BINDER-DRUG CONJUGATES (ADCS) AND USE THEREOF

Peptidomimetic protease inhibitors

Process for and intermediates in the preparation of canfosfamide and its salts

bioactive compositions and metabolites

Peptidomimetic protease inhibitors

ACETYLATED AMINO ACIDS AS ANTI-PLATELET AGENTS, NUTRITIONAL AND VITAMIN SUPPLEMENTS

Prodrug of an ICE inhibitor

Dipeptoid prodrugs and the use thereof

Acetylated amino acids as anti-platelet agents, nutritional and vitamin supplements

Inhibitors of Cancer Cell, T-Cell and Keratinocyte Proliferation

Gamma amino acid building blocks

Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease

Inhibitors for the soluble epoxide hydrolase

Auristatin drug linker conjugates

Prodrugs of GABA analogs, compositions and uses thereof

HCV NS-3 SERINE PROTEASE INHIBITORS

Peptidomimetic protease inhibitors

INTEGRIN TARGETED CYCLOPEPTIDE LIGANDS, THEIR PREPARATION AND USE

Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease

Depsipeptides and their therapeutic use

Depsipeptides and their therapeutic use

CYCLIC MALONAMIDES AS INHIBITORS OF A BETA PROTEIN PRODUCTION

CYCLIC MALONAMIDES AS INHIBITORS OF ABETA PROTEIN PRODUCTION

HCV NS-3 Serine Protease Inhibitors

Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease

RADIOFLUORINATION METHODS

Methods of treating using conjugates transported by a PEPT2 transporter

HEMIASTERLIN ANALOGS

CYCLIC MALONAMIDES AS INHIBITORS OF Abeta PROTEIN PRODUCTION

STILBENE DERIVATIVES AND METHODS OF INHIBITING CANCER CELL GROWTH AND MICROBIAL GROWTH

SMALL PEPTIDIC AND PEPTIDO-MIMETIC AFFINITY LIGANDS FOR FACTOR VIII AND FACTOR VIII-LIKE PROTEINS

INHIBITORS OF CANCER CELL, T-CELL AND KERATINOCYTE PROLIFERATION

Monomethylvaline compounds having phenylalanine carboxy modifications at the C-terminus

Biologically active peptides and compositions, their use

Anti-cancer compounds

Monomethylvaline compounds having phenylalanine side-chain replacements at the C-terminus

Prodrug of an ICE inhibitor

Cyclic malonamides as inhibitors of aβ protein production

Alkene Mimics

COMPOUNDS FOR SUSTAINED RELEASE OF ORALLY DELIVERED DRUGS

Use of Derivatives of Dipeptides for the Manufacture of of a Medicament for the Treamtent of Microbial Infections

Growth hormone releasing peptides

Novel Drugs for Dementia

Amino acid conjugates providing for sustained systemic concentrations of GABA analogues

Compounds for treating tumors

RECOMBINANT ANTI-CD30 ANTIBODIES AND USES THEREOF

Hemiasterlin Derivatives and Uses Thereof

Myd88 Homodimerization Inhibitors

Cyclic malonamides as inhibitors of Aβ protein production

Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them

Depeptidized inhibitors of hepatitis C virus NS3 protease

HCV NS-3 serine protease inhibitors

HCV NS-3 serine protease inhibitors

Tamandarin analogs and fragments thereof and methods of making and using

Inhibitors of hepatitis C virus NS3 protease

Deoxo-proline-containing tamandarin and didemnin analogs, dehydro-proline-containing tamandarin and didemnin analogs, and methods of making and using them

Acetylated amino acids as anti-platelet agents, nutritional and vitamin supplements

Didemnin analogs and fragments and methods of making and using them

Ketoamides with cyclic P4's as inhibitors of NS3 serine protease of hepatitis C virus

Inhibitors of cancer cell, T-cell and keratinocyte proliferation

Hemiasterlin affinity probes and their uses

Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs

Prodrugs of GABA analogs, compositions and uses thereof

Administration of HCV protease inhibitors in combination with food to improve bioavailability

Inhibitors for the soluble epoxide hydrolase

Pentapeptide compounds and uses related thereto

Anti-cancer compounds

Bile-acid conjugates providing for sustained systemic concentration of drugs

Statine derivatives for the treatment of Alzheimer's disease II

Process for the manufacture of disubstituted amines

Hemiasterlin derivatives and uses thereof

Synthesis of epoxide based inhibitors of cysteine proteases

Cyclic malonamides as inhibitors of Aβ protein protection

Process for and intermediates in the preparation of canfosfamide and its salts

3-Pyrrolidin-2-yl-propionic acid derivatives

Statine derivatives for the treatment of Alzheimer's disease III

Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease

Low molecular weight peptidomimetic growth hormone secretagogues

Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis

Hybrid molecules QA, wherein Q is an aminoquinoline and a is an antibiotic or a resistance enzyme inhibitor, their synthesis and their uses as antibacterial agent

Hepatitis C inhibitor peptide analogs

Novel amide derivatives as growth hormone secretagogues

Process for the synthesis of intermediates useful for the synthesis of tubulin inhibitors

Bile-acid conjugates for providing sustained systemic concentrations of drugs

Diamines as modulators of chemokine receptor activity

Bile-acid derived compounds for providing sustained systemic concentrations of drugs after oral administration

Substituted prolines as inhibitors of hepatitis C virus NS3 serine protease

Inhibitors of hepatitis C virus NS3 protease

Method of making tetrapeptide derivative TZT-1027 crystal

Ketoamides with cyclic P4'S as inhibitors of NS3 protease of hepatitis C virus

Derivatives of dehydrodidemnin B

Methods for identifying RNA binding compounds

Methods of screening agents, conjugates or conjugate moieties for transport by a PEPT2 transporter

Depsipeptide compound

Peptidomimetic protease inhibitors

Dipeptide inhibitors of β-secretase

Biologically active peptides and compositions, their use

Conjugates of ligand linker and cytotoxic agent and related composition and methods of use

Depeptidized inhibitors of hepatitis C virus NS3 protease

Vitronectin receptor antagonist pharmaceuticals

Bile-acid conjugates providing for sustained systemic concentration of drugs

Growth hormone releasing peptides

Pentapeptide compounds and uses related thereto

Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis

Novel statine derivatives for the treatment of Alzheimer's disease

Compounds for sustained release of orally delivered drugs

Compounds for treating tumors

Cyclic malonamides as inhibitors of A-β protein production

Pentapeptide compounds and uses related thereto

Bivalent inhibitors of Glutathione-S-Transferases

Modified polynucleotides and uses thereof